In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
Authors:
- Michel AttalMAMichel Attal
- Christiane RusalenCRChristiane Rusalen
- John WijdenesJWJohn Wijdenes
- Patrice MannoniPMPatrice Mannoni
- Dominique MaraninchiDMDominique Maraninchi
- 1 July 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (7) , 1759-1762
Abstract
Whether interleukin 6 (IL6) is an autocrine or paracrine myeloma cell growth factor in vivo remains unresolved. To identify which cells are producing IL 6 in vivo, we have studied the IL 6 gene expression in bone marrow mononuclear cells (BMMC) of 19 patients with multiple myeloma (MM) and in peripheral blood mononuclear cells (PBMC) of 9 patients with plasma cell leukemia (PCL). We found that the IL 6 gene was transcribed by BMMC of most patients with MM (79%). Further, IL 6 mRNA was not produced by purified myeloma cells from patients with either MM (5 patients) or PCL, but by the bone marrow environment, mainly by monocytes and myeloid cells (CD13+CD15+ cells). For 2 patients with PCL, for whom PBMC and BMMC samples were available, IL 6 mRNA could be detected in BMMC but not in PBMC. Finally, no IL 6 mRNA was detected in five freshly established IL 6‐dependent myeloma cell lines. The present data give a clear‐cut demonstration of the paracrine origin of IL 6 in vivo in human MM.Keywords
This publication has 13 references indexed in Scilit:
- Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.Journal of Experimental Medicine, 1990
- Characterization of a new IgGλ myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myelomaBritish Journal of Haematology, 1990
- Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.Journal of Experimental Medicine, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Interleukin 6 gene expression in normal and neoplastic B cells.Journal of Clinical Investigation, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.Journal of Experimental Medicine, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- A Growth Factor Required by Plasmacytoma Cells In Vitro1986
- Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissuesNucleic Acids Research, 1984